Konstantinos G. Stravodimos

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification.

Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 24, 2026

Circulating ERVFRD-1 and MFSD2A Are Associated with Immunotherapy Response in Metastatic Clear Cell Renal Cell Carcinoma.

Circulating ERVFRD-1 and MFSD2A Are Associated with Immunotherapy Response in Metastatic Clear Cell Renal Cell Carcinoma.

Journal: Cancers

Published: January 15, 2026

Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression.

Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression.

Journal: The Journal of biological chemistry

Published: January 14, 2026

Penile Mondor Disease Following Circumcision: Diagnostic Insights from Color Doppler Ultrasound.

Penile Mondor Disease Following Circumcision: Diagnostic Insights from Color Doppler Ultrasound.

Journal: Diagnostics (Basel, Switzerland)

Published: December 29, 2025

Results of rotational thromboelastometry confirm venous thromboembolic risk prediction in urologic patients.

Results of rotational thromboelastometry confirm venous thromboembolic risk prediction in urologic patients.

Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica

Published: November 03, 2025

Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer.

Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer.

Journal: Proteomics

Published: October 29, 2025

Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.

Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.

Journal: International journal of cancer

Published: February 05, 2025

Fusion MRI/Ultrasound-Guided Transperineal Biopsy: A Game Changer in Prostate Cancer Diagnosis.

Fusion MRI/Ultrasound-Guided Transperineal Biopsy: A Game Changer in Prostate Cancer Diagnosis.

Journal: Journal of clinical medicine

Published: November 30, 2024

Magnetic resonance imaging/ultrasound fusion-guided transperineal prostate biopsy: Protocol for a clinic-based surgical technique.

Magnetic resonance imaging/ultrasound fusion-guided transperineal prostate biopsy: Protocol for a clinic-based surgical technique.

Journal: Journal of biological methods

Published: November 11, 2024

Up-regulation of Cuproptosis-related lncRNAS in Patients Receiving Immunotherapy for Metastatic Clear Cell Renal Cell Carcinoma Indicates Progressive Disease.

Up-regulation of Cuproptosis-related lncRNAS in Patients Receiving Immunotherapy for Metastatic Clear Cell Renal Cell Carcinoma Indicates Progressive Disease.

Journal: In vivo (Athens, Greece)

Published: August 29, 2024

Intravesical Administration of Durvalumab for High-risk Non-muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group.

Intravesical Administration of Durvalumab for High-risk Non-muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group.

Journal: European urology

Published: July 30, 2024

The Role of Inflammatory Biomarkers in the Pre-Biopsy Risk Stratification of Patients with Suspicious MRI Lesions of the Prostate: Where Should We Head?

The Role of Inflammatory Biomarkers in the Pre-Biopsy Risk Stratification of Patients with Suspicious MRI Lesions of the Prostate: Where Should We Head?

Journal: Current medicinal chemistry

Published: July 17, 2024

Showing 1-12 of 93

Last Updated: 09/26/2026